Notícias do Mercado de Ações

Últimas notícias financeiras · Atualizado Jul 28, 2026

▬ mixed

Ripple (XRP) Fechou 10 Grandes Negócios Este Ano: Aqui Está o Quadro de Pontuação para Cada Parceria

Ripple (XRP) Has Closed 10 Major Deals This Year: Here’s the Scoreboard for Each Partnership

Despite Ripple's infrastructure wins, XRP's price performance remains lackluster due to regulatory uncertainty and limited token utility. The market is …

Yahoo Finance · Mai 12, 2026
ERAS
▼ bear…

JPMorgan Recomenda Comprar Ações da Erasca (ERAS) nos Níveis Atuais

JPMorgan Recommends Buying Erasca (ERAS) Stock at Current Levels

The panel consensus is bearish on Erasca (ERAS), with concerns around 'not fully clean' Phase 1 data, safety caveats, and …

Yahoo Finance · Mai 12, 2026
TNGX
▬ mixed

Stifel continua otimista com a Tango Therapeutics (TNGX)

Stifel Remains Bullish on Tango Therapeutics (TNGX)

The panel's discussion on TNGX revolves around the potential of its PRMT5/RAS(ON) combo in pancreatic cancer, with a cash runway …

Yahoo Finance · Mai 12, 2026
ORKA
▬ mixed

Leerink Partners Aumenta PT em Oruka Therapeutics, Inc. (ORKA)

Leerink Partners Lifts PT on Oruka Therapeutics, Inc. (ORKA)

ORKA-001's Phase 2a results are impressive, but its path to market is uncertain due to manufacturing challenges, competition, and commercial …

Yahoo Finance · Mai 12, 2026
ANAB
▬ mixed

AnaptysBio (ANAB) é uma das Ações de Saúde com Melhor Desempenho até Agora em 2026?

Is AnaptysBio (ANAB) One of the Best Performing Healthcare Stocks so Far in 2026?

The panel is divided on ANAB's spinoff of TRAX, with some seeing it as a value-enhancing move that separates stable …

Yahoo Finance · Mai 12, 2026
RVMD
▬ mixed

Revolution Medicines (RVMD) Recebe Carta "Safe to Proceed" da FDA para Daraxonrasib

Revolution Medicines (RVMD) Receives FDA’s “Safe to Proceed” Letter for Daraxonrasib

The panel is mixed on RVMD's 'safe to proceed' EAP, with concerns about the lack of efficacy data, manufacturing challenges, …

Yahoo Finance · Mai 12, 2026
ACHC
▬ mixed

RBC Capital Aumenta PT da Acadia Healthcare Company (ACHC) Após Superar Lucros do Q1

RBC Capital Lifts PT on Acadia Healthcare Company (ACHC) Following Q1 Earnings Beat

While ACHC's Q1 earnings beat and upgrades suggest potential for EBITDA improvement and a 'harvest' from underperforming facilities, the consensus …

Yahoo Finance · Mai 12, 2026
TWST
▬ mixed

Twist Bioscience Corporation (TWST) Anuncia Resultados Financeiros do Q2 2026

Twist Bioscience Corporation (TWST) Announces Q2 2026 Financial Results

The panelists agree that Twist Bioscience has shown operational momentum with 13 consecutive quarters of growth and a 19% YoY …

Yahoo Finance · Mai 12, 2026
AVGO
▬ mixed

Goldman Sachs redefine a previsão de ações da Broadcom

Goldman Sachs resets Broadcom stock forecast

The panel is divided on Broadcom's VMware integration, with bulls focusing on potential margin expansion and AI momentum, while bears …

Yahoo Finance · Mai 12, 2026
CGON
▬ mixed

RBC Capital Aumenta PT em CG Oncology (CGON), Chama PIVOT-006 de Catalisador Complexo

RBC Capital Lifts PT on CG Oncology (CGON), Calls PIVOT-006 a Complex Catalyst

CG Oncology's stock performance is heavily reliant on the June PIVOT-006 data, with a high risk of a 'sell the …

Yahoo Finance · Mai 12, 2026
GWW
▬ mixed

Destaques da Chamada de Lucros do W.W. Grainger no Primeiro Trimestre

W.W. Grainger Q1 Earnings Call Highlights

Panelists have mixed views on Grainger's Q1 results and future prospects. While some highlight the impressive EPS growth and margin …

Yahoo Finance · Mai 12, 2026
S U
▬ mixed

Ações Europeias Vistas Abrindo em Tom Cauteloso

European Shares Seen Opening On Cautious Note

The panelists generally agree that European stocks face headwinds due to stretched valuations and uncertainty around central bank policies, with …

Nasdaq · Mai 12, 2026